RACHEL HILLIARD: Open Payments
NPI 1346886728 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,143 in 110 payments from 20 companies in 2025. Trend: 2023 $1,882 · 2024 $1,710 · 2025 $2,143
Food & beverage: $2,143
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $370 |
| Novo Nordisk Inc | 12 | $259 |
| GlaxoSmithKline, LLC. | 15 | $254 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $200 |
| ABBVIE INC. | 8 | $183 |
| PFIZER INC. | 13 | $155 |
| Arcutis Biotherapeutics, Inc. | 1 | $125 |
| Exact Sciences Corporation | 7 | $122 |
| Paratek Pharmaceuticals, Inc. | 6 | $102 |
| Amgen Inc. | 4 | $76 |
Products named: TRELEGY ELLIPTA, Kerendia, FARXIGA, Ozempic, NURTEC ODT, Cologuard Collection Kit, UBRELVY, Rybelsus.
Industry payments across AL — which companies pay providers there.
